More on Kimberly-Clark's (KMB) Q2: Overall, revenue growth comes in flat. Organic revenues rise...

|About: Kimberly-Clark Corporation (KMB)|By:, SA News Editor

More on Kimberly-Clark's (KMB) Q2: Overall, revenue growth comes in flat. Organic revenues rise 3% as the international business offsets "mixed volume performance" in developed countries. Adjusted operating profit rises 6% and adjusted operating margin climbs 80 basis points. An interesting tidbit from the segment results which may have wider implications for the market: "Surgical and infection prevention volumes were down low-single digits, primarily due to declines in exam gloves" and medical device volumes posted only a slight gain after logging double-digit growth in Q2 2012. Full year outlook: $5.60-5.75/ share. (PR)